ANI Pharmaceuticals
ANIP
ANIP
182 hedge funds and large institutions have $764M invested in ANI Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 55 increasing their positions, 53 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
0% less capital invested
Capital invested by funds: $766M → $764M (-$2.8M)
9% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 34
2% less funds holding
Funds holding: 186 → 182 (-4)
Holders
182
Holding in Top 10
1
Calls
$1.33M
Puts
$248K
Top Buyers
| 1 | +$15.3M | |
| 2 | +$13.5M | |
| 3 | +$12.7M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$11M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.63M |
Top Sellers
| 1 | -$15.8M | |
| 2 | -$9.6M | |
| 3 | -$8.43M | |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$6.49M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$5.17M |